V58M (p.Val58Met) variant of NPPA (Natriuretic peptides A)

V58M (p.Val58Met) in NPPA (Natriuretic peptides A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Atrial fibrillation, familial, 6. The available variant effect predictions contribute to a CATVariant prioritization score of 0.04 / 1. The record also includes population frequency data and structural context.

V58M (p.Val58Met) variant details